Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Alvaro Urbano-Ispizua"'
Autor:
Marta Gómez-Hernando, Luis F. Quintana, María Suárez-Lledo, Nuria Martínez-Cibrian, Andrea Rivero, Sonia Ruiz-Boy, Ester Carcelero, Paula Mate, Gisela Riu, Inés Monge, Anna Serrahima, Maria Teresa Solano, Laura Rosiñol, Jordi Esteve, Alvaro Urbano-Ispizua, Enric Carreras, Francesc Fernández-Avilés, Carmen Martínez, Montserrat Rovira, Maria Queralt Salas
Publikováno v:
Bone Marrow Transplantation. 58:212-214
Autor:
Christian Chabannon, Florent Malard, Katya Mauff, Annalisa Ruggeri, Sara Ghorashian, Alvaro Urbano-Ispizua, Per Ljungman, Jürgen Kuball, Rafael de la Cámara, Jorinde Hoogenboom, Meltem Kurt Yuksel
Publikováno v:
Bone Marrow Transplantation
Publikováno v:
Bone marrow transplantation. 57(2)
In February 2021, the ‘Advanced Therapy Medicinal Product’ (ATMP) ARI-0001 (CART19-BE-01), developed at Hospital Clínic de Barcelona (Spain), received authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) under the ‘ho
Autor:
Montserrat Rovira, Luis Gerardo Rodríguez-Lobato, Alvaro Urbano-Ispizua, Nacira Arab, Pilar Ayora, Cristina Gallego, Joan Sánchez, Laura Rosiñol, Alexandra Pedraza, Noemí Llobet, María Suárez-Lledó, Ariadna Domenech, Carmen Martinez, María Teresa Solano, Joan Cid, Nuria Borràs, Francesc Fernández-Avilés, Alexandra Martínez-Roca, Pedro Marín, Carla Ramos, Anna Serrahima, Esther Carcelero, Gonzalo Gutiérrez-García, María Ángeles Álvarez, María Dolores Herrera, Miquel Lozano
Publikováno v:
Bone marrow transplantation. 55(5)
In 2015, we implemented an at-home allogeneic haematopoietic cell transplant (allo-HCT) program. Between 2015 and 2018, 252 patients underwent allo-HCT; 41 patients underwent allo-HCT in the at-home program (46% myeloablative; 63% unrelated donor; 32
Autor:
María Suárez-Lledó, Alex Bataller, Joan Cid, Carlos Fernández de Larrea, Enric Carreras, Jordi Esteve, María Teresa Cibeira, Joan Bladé, Carmen Martinez, Laura Rosiñol, Julio Solano-Vega, Francesc Fernández-Avilés, María Teresa Solano, Nuria Borràs, Miquel Lozano, Gonzalo Gutiérrez-García, Montserrat Rovira, Pedro Marín, Ariadna Domenech, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Noemí Llobet, Alvaro Urbano-Ispizua
Publikováno v:
Bone Marrow Transplantation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Autologous stem cell transplant (ASCT) has demonstrated to be an effective treatment for patients with light-chain (AL) amyloidosis. However, a high transplant-related mortality (TRM) rate was reported in previous series of patients and questioned th
Autor:
N Creus, M Rovira, Alvaro Urbano-Ispizua, Cristina Gallego, Enric Carreras, C F de Larrea, C Martínez, Laura Rosiñol, Laura Magnano, J. Bladé, Anna Gaya, Francesc Fernández-Avilés, Gonzalo Gutiérrez-García, MT Cibeira, Adelina Hernando, Juan-Gonzalo Correa, X Andrade, Nuria Martínez-Cibrian, María Suárez-Lledó
Publikováno v:
Bone Marrow Transplantation. 51:593-595
Autor:
Alvaro Urbano-Ispizua, Francesc Fernández-Avilés, M Rosales, L Rodriguez-Carunchio, C Martínez, M Rovira, M Cuatrecasas, J Llach, Xavier Calvo, Enric Carreras, Laura Rosiñol
Publikováno v:
Bone Marrow Transplantation. 47:694-699
Gastrointestinal (GI) GVHD after allo-SCT is diagnosed on the basis of symptoms and findings in endoscopic mucosal biopsy specimens. However, GI symptoms often persist despite treatment and whether a second endoscopy may be helpful in determining the
Publikováno v:
Bone Marrow Transplantation. 34:855-875
This 2002 European Group for Blood and Marrow Transplantation (EBMT) activity survey concentrates on current status, increase and decrease in haematopoietic stem cell transplantation (HSCT) activity in Europe and investigates the association of trans
Autor:
A. Leon, Carlos Solano, M. D. Caballero, M Gómez-Núñez, José-María Moraleda, Carmen Canals, Juan Besalduch, Jesús-F San Miguel, Alvaro Urbano-Ispizua, Rodrigo Martino, José Antonio Pérez-Simón, M.V. Mateos, Josep Sarrá, Jordi Sierra
Publikováno v:
Bone Marrow Transplantation. 33:477-482
Over a 3-year period, 145 patients ineligible for myeloablative conditioning underwent reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (SCT) from an HLA-identical sibling in a prospective study. The median age was 54 year
Autor:
Eva Giné, Jordi Esteve, Montserrat E, Elisabet Nadal, Francesc Fernández-Avilés, M Rovira, Alvaro Urbano-Ispizua, J. Bladé, Enric Carreras, Laura Rosiñol, C Martínez, Pedro Marín
Publikováno v:
Bone Marrow Transplantation. 33:61-64
High-dose therapy (HDT) followed by autologous stem cell support is widely used as intensification treatment in patients with multiple myeloma (MM) responsive to the initial chemotherapy. However, there is growing evidence that only the subset of pat